Literature DB >> 1637885

A study of von Willebrand's disease in Jordan.

A S Awidi1.   

Abstract

This work reports on the results of a 9-year study of von Willebrand's disease and its subtypes in Jordan, a country with a predominantly Arab population. There were a total of 65 patients in 32 families. Detailed study of 61 patients including von Willebrand factor multimers was done for the purpose of subtyping them. Type I and variants were seen in 36 patients (59%). Type II A and variants with decreased ristocetin response accounted for seven patients (11.5%), while 11 (18%) were of type II B. The severe type (type III) accounted for seven patients (11.5%). Von Willebrand's disease was the second most commonly seen inherited bleeding disorder after hemophilia A. It is concluded that although the observed frequency of von Willebrand's disease in this study in Jordan is lower than that in Europe and the USA, the true prevalence cannot be ascertained since many of the mild cases presumably were missed because of referral patterns. Type I and its variants was the most common type found, but the observed frequency of types II B and III was more than that reported in Europeans and Americans.

Entities:  

Mesh:

Year:  1992        PMID: 1637885     DOI: 10.1007/bf01695475

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  14 in total

Review 1.  The von Willebrand factor gene and genetics of von Willebrand's disease.

Authors:  D Ginsburg
Journal:  Mayo Clin Proc       Date:  1991-05       Impact factor: 7.616

2.  A relatively high frequency of severe (type III) von Willebrand's disease in Israel.

Authors:  S A Berliner; U Seligsohn; A Zivelin; E Zwang; G Sofferman
Journal:  Br J Haematol       Date:  1986-03       Impact factor: 6.998

Review 3.  Von Willebrand's disease today.

Authors:  I M Nilsson; L Holmberg
Journal:  Clin Haematol       Date:  1979-02

Review 4.  The von Willebrand syndrome.

Authors:  A L Bloom
Journal:  Semin Hematol       Date:  1980-10       Impact factor: 3.851

5.  Incidence of severe von Willebrand's disease.

Authors:  H J Weiss; A P Ball; P M Mannucci
Journal:  N Engl J Med       Date:  1982-07-08       Impact factor: 91.245

6.  Von Willebrand factor multimer patterns in von Willebrand's disease.

Authors:  L W Hoyer; C R Rizza; E G Tuddenham; C A Carta; H Armitage; F Rotblat
Journal:  Br J Haematol       Date:  1983-11       Impact factor: 6.998

Review 7.  von Willebrand factor and von Willebrand disease.

Authors:  Z M Ruggeri; T S Zimmerman
Journal:  Blood       Date:  1987-10       Impact factor: 22.113

8.  Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization.

Authors:  D Ginsburg; R I Handin; D T Bonthron; T A Donlon; G A Bruns; S A Latt; S H Orkin
Journal:  Science       Date:  1985-06-21       Impact factor: 47.728

9.  Epidemiological investigation of the prevalence of von Willebrand's disease.

Authors:  F Rodeghiero; G Castaman; E Dini
Journal:  Blood       Date:  1987-02       Impact factor: 22.113

10.  Congenital hemorrhagic disorders in Jordan.

Authors:  A S Awidi
Journal:  Thromb Haemost       Date:  1984-07-29       Impact factor: 5.249

View more
  3 in total

1.  Single-Center Experience of von Willebrand Disease (vWD) Among Patients with Menorrhagia: A Diagnosis which could be Missed.

Authors:  Rosline Hassan; Wan Aswani Wan Yusof; Nik Hazlina Nik Hussain; Wan Zaidah Abdullah
Journal:  Indian J Hematol Blood Transfus       Date:  2012-02-01       Impact factor: 0.900

2.  Prevalence of Bleeding Symptoms among Adolescents and Young Adults in the Capital City of Saudi Arabia.

Authors:  Tarek Owaidah; Mahasen Saleh; Hazzah Alzahrani; Mahmood Abu-Riash; Ali Al Zahrani; Mohammed Almadani; Ayman Alsulaiman; Abdulmajeed Albanyan; Khawar Siddiqui; Khalid Al Saleh; Abdulkareem Al Momen
Journal:  Adv Hematol       Date:  2018-05-02

3.  The prevalence of self-reported bleeding tendency symptoms among adolescents in Almadinah Almunawwarah, Kingdom of Saudi Arabia.

Authors:  Mohammed A Zolaly; Ahmad Tarwah; Mohammed Albalawi; Turki Alwasaidi; Tarek Owaidah
Journal:  J Family Med Prim Care       Date:  2021-02-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.